Report overview
This report contains market size and forecasts of Follicular Thyroid Cancer Drug in global, including the following market information:
Global Follicular Thyroid Cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Follicular Thyroid Cancer Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Follicular Thyroid Cancer Drug companies in 2021 (%)
The global Follicular Thyroid Cancer Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cabozantinib S-Malate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Follicular Thyroid Cancer Drug include AstraZeneca PLC, Exelixis, Inc., GlaxoSmithKline plc, Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Follicular Thyroid Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Thyroid Cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Follicular Thyroid Cancer Drug Market Segment Percentages, by Type, 2021 (%)
Cabozantinib S-Malate
Dabrafenib Mesylate
Everolimus
Sunitinib Malate
Others
Global Follicular Thyroid Cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Follicular Thyroid Cancer Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Follicular Thyroid Cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Follicular Thyroid Cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Follicular Thyroid Cancer Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Follicular Thyroid Cancer Drug revenues share in global market, 2021 (%)
Key companies Follicular Thyroid Cancer Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Follicular Thyroid Cancer Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca PLC
Exelixis, Inc.
GlaxoSmithKline plc
Novartis AG
Pfizer Inc.
